Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | AZN | AMGN | GILD | GSK |
| Company | Crispr Therapeutics Ag | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 54.04 | 206.60 | 372.01 | 150.58 | 59.87 |
| High | 55.05 | 207.69 | 377.00 | 153.26 | 60.05 |
| Low | 53.16 | 205.45 | 371.39 | 150.09 | 59.33 |
| Latest | 53.62 | 205.81 | 374.33 | 151.88 | 59.53 |
| Change | -1.02 | -0.64 | -1.17 | +0.76 | -0.84 |
| % Change | -1.87% | -0.31% | -0.31% | +0.50% | -1.39% |
| Volume | 444,366 | 714,511 | 794,121 | 1,711,371 | 2,550,064 |
| 20-Day Average Volume | 1,587,653 | 2,859,781 | 2,912,629 | 8,146,831 | 6,471,579 |
| Previous Close | 54.64 | 206.45 | 375.50 | 151.12 | 60.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 51.69 | 194.62 | 361.05 | 147.13 | 56.07 |
| 20-Day Raw Stochastic | 56.10% | 78.60% | 79.93% | 79.42% | 84.15% |
| 20-Day Relative Strength | 51.47 | 63.94 | 62.70 | 64.17 | 68.61 |
| Weighted Alpha | +12.56 | +48.29 | +32.83 | +48.65 | +74.38 |
| Today's Opinion | 72% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | Hold | 64% Buy | 88% Buy | 96% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.44% since 02/12/26 | +0.88% since 02/12/26 | +2.59% since 02/12/26 | +0.05% since 02/12/26 | +1.84% since 02/12/26 |
| Low | 49.62 on 02/13/26 | 204.09 on 02/13/26 | 361.71 on 02/13/26 | 150.09 on 02/20/26 | 58.56 on 02/13/26 |
| High | 54.98 on 02/20/26 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | +2.72% since 01/20/26 | +14.70% since 01/20/26 | +13.50% since 01/20/26 | +22.35% since 01/20/26 | +25.11% since 01/20/26 |
| Low | 45.53 on 02/05/26 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 47.77 on 01/21/26 |
| High | 60.86 on 01/22/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | +9.64% since 11/20/25 | +16.33% since 11/20/25 | +11.78% since 11/20/25 | +21.51% since 11/20/25 | +29.29% since 11/20/25 |
| Low | 45.53 on 02/05/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 46.47 on 11/21/25 |
| High | 60.86 on 01/22/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | +1.83% since 08/20/25 | +28.12% since 08/20/25 | +26.72% since 08/20/25 | +27.92% since 08/20/25 | +48.78% since 08/20/25 |
| Low | 45.53 on 02/05/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 78.48 on 10/08/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,244,621 | 323,550,432 | 202,420,032 | 187,491,552 | 124,037,000 |
| Shares Outstanding, K | 95,985 | 1,550,908 | 539,068 | 1,240,680 | 2,038,406 |
| Annual Sales | 3,510,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -581,600,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 860,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -130,610,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 1.72 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.37 on 02/12/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.478 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.76 | 17.38 | 18.74 | 13.54 |